Dezheng Huo to Primary Myelofibrosis
This is a "connection" page, showing publications Dezheng Huo has written about Primary Myelofibrosis.
Connection Strength
0.235
-
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis. Blood Adv. 2024 Nov 26; 8(22):5735-5743.
Score: 0.235
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.